Akso Health Group DRC

Company Profile

Akso Health Group DRC had its IPO on 2006-12-28 under the ticker symbol AHG.

The company operates in the Healthcare sector and Medical Distribution industry. Akso Health Group DRC has a staff strength of 182 employees.

Stock update

Shares of Akso Health Group DRC opened at $1.03 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.91 - $1.04, and closed at $1.02.

This is a 0% increase from the previous day's closing price.

A total volume of 208,072 shares were traded at the close of the day’s session.

In the last one week, shares of Akso Health Group DRC have increased by +22.89%.

Akso Health Group DRC's Key Ratios

Akso Health Group DRC has a market cap of $9.53 million, indicating a price to book ratio of 0.524 and a price to sales ratio of 15.3706.

In the last 12-months Akso Health Group DRC’s revenue was $17.94 million with a gross profit of $916226 and an EBITDA of $-8285781. The EBITDA ratio measures Akso Health Group DRC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Akso Health Group DRC’s operating margin was -46.35% while its return on assets stood at -19.45% with a return of equity of -48.21%.

In Q3, Akso Health Group DRC’s quarterly earnings growth was a positive 0% while revenue growth was a positive 4727.7%.

Akso Health Group DRC’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.24 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Akso Health Group DRC’s profitability.

Akso Health Group DRC stock is trading at a EV to sales ratio of 7.3937 and a EV to EBITDA ratio of -0.2288. Its price to sales ratio in the trailing 12-months stood at 15.3706.

Akso Health Group DRC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$20.91 million

Total Liabilities

$10.98 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Akso Health Group DRC ended 2024 with $20.91 million in total assets and $0 in total liabilities. Its intangible assets were valued at $20.91 million while shareholder equity stood at $9.91 million.

Akso Health Group DRC ended 2024 with $0 in deferred long-term liabilities, $10.98 million in other current liabilities, 6977.00 in common stock, $-52297338.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9.99 million and cash and short-term investments were $9.99 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Akso Health Group DRC’s total current assets stands at $20.87 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.93 million compared to accounts payable of $0 and inventory worth $899555.00.

In 2024, Akso Health Group DRC's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Akso Health Group DRC paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.02

52-Week High

$2.34

52-Week Low

$0.2

Analyst Target Price

$

Akso Health Group DRC stock is currently trading at $1.02 per share. It touched a 52-week high of $2.34 and a 52-week low of $2.34. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.45 and 200-day moving average was $0.39 The short ratio stood at 0.59 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 168.2% are held by institutions.